微创与开腹肝切除治疗肝泡型棘球蚴病的对比:单中心回顾性研究
该单中心回顾性研究纳入2010年1月至2026年3月因肝泡型棘球蚴病行肝切除的126例患者(开腹87例,微创39例),采用倾向性评分重叠权重调整基线差异。微创组病变较小、分期较早,术中出血、Clavien-Dindo≥II级并发症、严重并发症及住院时间均较低,调整后疾病进展风险未增加(HR 0.47,95%CI 0.07-3.22;p=0.44)。
要点
- 在经选择的肝泡型棘球蚴病患者中,微创肝切除与较好的围术期结局相关。
- 调整后微创未增加疾病进展风险,但事件数少、随访短,长期等效性尚不能结论。
- 微创组病变较小、分期较早,解读围术期优势时需考虑选择偏倚。
核心结论
- 在经选择的肝泡型棘球蚴病患者中,微创手术与有利的围术期结局相关。
- 调整后未检测到疾病进展风险增加,但事件数有限且随访较短,尚不能得出长期等效的结论。
研究设计与样本
- 单中心回顾性研究,纳入2010年1月至2026年3月因肝泡型棘球蚴病行肝切除的126例患者。
- 开腹手术87例,微创手术39例,采用倾向性评分重叠权重调整基线差异。
主要发现
- 微创组病变较小、疾病分期较早。
- 两组手术时间相似。
- 微创组术中出血、Clavien-Dindo≥II级并发症、严重并发症及住院时间均较低。
- 重叠权重调整后,微创与疾病进展风险增加无关(HR 0.47,95%CI 0.07-3.22;p=0.44)。
- 微创组无死亡发生,总生存的调整后HR无法估计。
关键数值与推荐
- 微创组与开腹组分别有39例和87例患者。
- 疾病进展的调整后HR为0.47(95%CI 0.07-3.22;p=0.44)。
临床怎么用
- 在经选择的肝泡型棘球蚴病患者中,微创肝切除可作为以疾病控制为导向的手术策略的选项之一。
- 术前评估需关注病变大小与疾病分期,微创优势可能部分反映选择偏倚。
- 长期肿瘤学等效性需更长的随访和更多事件数验证。
局限性
- 单中心回顾性设计,存在选择偏倚可能。
- 微创组事件数有限且随访较短,长期等效性无法结论。
- 微创组无死亡发生,总生存的调整后HR无法估计。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The surgical strategy for hepatic alveolar echinococcosis (AE) differs from that for typical malignant tumors, as treatment is not solely determined by the feasibility of complete (R0) resection. While complete resection remains the preferred goal, cytoreductive surgery combined with albendazole therapy is considered in selected cases. The role of minimally invasive surgery (MIS) within this disease-control oriented strategy remains unclear. METHODS: We retrospectively analyzed 126 patients who underwent liver resection for hepatic AE between January 2010 and March 2026: 87 underwent open surgery and 39 underwent MIS. Perioperative and disease-control outcomes were compared, with propensity score overlap weighting used to adjust for baseline differences. RESULTS: The MIS group had smaller lesions and less advanced disease. Operative time was similar, whereas blood loss, Clavien-Dindo grade ≥II morbidity, severe morbidity, and hospital stay were lower in the MIS group. After overlap weighting, MIS was not associated with an increased hazard of disease progression (hazard ratio 0.47, 95% confidence interval 0.07-3.22; p=0.44). An adjusted hazard ratio for overall survival was not estimable because no deaths occurred in the MIS group. CONCLUSIONS: In selected patients with hepatic AE, MIS was associated with favorable perioperative outcomes. Although no increased risk of disease progression was detected after adjustment, limited events and shorter follow-up preclude conclusions regarding long-term equivalence.
引用
- Nagatsu A, Kakisaka T, Shichi S, et al. Minimally invasive versus open liver resection for hepatic alveolar echinococcosis within a disease-control oriented surgical strategy: a single-center retrospective study. Surg Endosc. 2026. PMID: 42686843. doi:10.1007/s00464-026-13339-7
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。